Appears on
Articles3
THC/CBD Combination Eases Agitation in Dementia: AAIC 2026
A THC and CBD combination eased agitation in people with late-stage dementia in a new randomised, placebo-controlled trial presented at AAIC 2026. The post THC/CBD Combination Eases Agitation in Dementia: AAIC 2026 appeared first on European Medical Journal .
Alzheimer’s Blood Test Predicts Decline Over 10 Years: AAIC 2026
A blood test for the Alzheimer's biomarker p-tau217 can forecast cognitive decline years before symptoms develop. The post Alzheimer’s Blood Test Predicts Decline Over 10 Years: AAIC 2026 appeared first on European Medical Journal .
Soccer Players Show Altered Brain Health in Midlife: AAIC 2026
New data reveal higher depression, anxiety, and brain volume changes in former soccer players, highlighting the need for further study of neurodegenerative disease risk in players. The post Soccer Players Show Altered Brain Health in Midlife: AAIC 2026 appeared first on European Medical Journal .